Randomized, Controlled Trial of Atomoxetine for Attention-Deficit/Hyperactivity Disorder in Adolescents With Substance Use Disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 49, Issue 6, 2010, Pages 573-582

  Thurstone, Christian ^a   Riggs, Paula D ^a   Salomonsen Sautel, Stacy ^a   Mikulich Gilbertson, Susan K ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

adolescent; atomoxetine; attention deficit hyperactivity disorder; substance use disorder

Indexed keywords

ATOMOXETINE; PLACEBO;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALCOHOL ABUSE; ARTHRALGIA; ARTICLE; ATTENTION DEFICIT DISORDER; BLURRED VISION; CANNABIS ADDICTION; CHECKLIST; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; CONCENTRATION LOSS; CONDUCT DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DROWSINESS; DRUG ABUSE; DRUG DOSE INCREASE; DRUG OVERDOSE; EFFECT SIZE; EXCITABILITY; FEMALE; FEVER; HEARTBURN; HUMAN; IRRITABILITY; LONELINESS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MUSCLE CRAMP; NAUSEA; NOSE CONGESTION; OUTCOME ASSESSMENT; PALLOR; PATIENT ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SIDE EFFECT; SLEEP DISORDER; SLURRED SPEECH; SPEECH DISORDER; SUBSTANCE ABUSE; SWEATING; TACHYCARDIA; TIC; TOBACCO DEPENDENCE; TREMOR; URINE INCONTINENCE; VOMITING; XEROSTOMIA;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHECKLIST; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MOTIVATION; PROPYLAMINES; SUBSTANCE-RELATED DISORDERS;

EID: 77952320208     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/00004583-201006000-00006     Document Type: Article

References (29)

1. Dennis M., Godley S.H., Diamond G., et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abuse Treat 27 (2004) 197-213
2. Greenbaum P.E., Foster-Johnson L., and Petrila A. Co-occurring addictive and mental disorders among adolescents: prevalence research and future directions. Am J Orthopsychiatry 66 (1996) 52-60
3. Horner B.R., and Scheibe K.E. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry 36 (1997) 30-36
4. Wise B.K., Cuffe S.P., and Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat 21 (2001) 161-165
5. Riggs P.D., Hall S.K., Mikulich-Gilbertson S.K., Lohman M., and Kayser A. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry 43 (2004) 420-429
6. Szobot C.M., Rohde L.A., Katz B., et al. A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder. Braz J Med Biol Res 41 (2008) 250-257
7. Schubiner H., Saules K.K., Arfken C.L., et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 10 (2002) 286-294
8. Levin F.R., Evans S.M., Brooks D.J., Kalbag A.S., Garawi F., and Nunes E.V. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 81 (2006) 137-148
9. Levin F.R., Evans S.M., Brooks D.J., and Garawi F. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 87 (2007) 20-29
10. Wilens T.E., Adler L.A., Weiss M.D., et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 96 (2008) 145-154
11. Heil S.H., Holmes H.W., Bickel W.K., et al. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend 67 (2002) 149-156
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition (1994), American Psychiatric Association, Washington, DC
13. Riggs P.D., Mikulich-Gilbertson S.K., Davies R.D., Lohman M., Klein C., and Stover S.K. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med 161 (2007) 1026-1034
14. Waldron H.B., Slesnick N., Brody J.L., Turner C.W., and Peterson T.R. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol 69 (2001) 802-813
15. Ambrosini P.J. Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J Am Acad Child Adolesc Psychiatry 39 (2000) 49-58
16. Adler L.A., Goodman D.W., Kollins S.H., et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69 (2008) 1364-1373
17. Adler L.A., Zimmerman B., Starr H.L., et al. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol 29 (2009) 239-247
18. Bostic J.Q., Biederman J., Spencer T.J., et al. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. J Child Adolesc Psychopharmacol 10 (2000) 205-216
19. Conners C.K., and Barkley R.A. Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 21 (1985) 809-843
20. Sobell L.C., and Sobell S.M. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten R., and Allen J. (Eds). Measuring Alcohol Consumption: Psychosocial and Biochemical Methods (1992), Humana Press, Totowa, NJ 41-72
21. Klein R.G., Barkley R.A., Campbell M., Leckman J.F., Ryan N.D., Solanto M.V., and Whalen C.K. AH. In: Prien R.F., and Robinson D.S. (Eds). Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines (1994), Raven Press, New York
22. Brent D., Emslie G., Clarke G., et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. J Am Med Assoc 299 (2008) 901-913
23. SPSS Inc. SPSS for Windows, Version 15.0 (2008), SPSS Inc, Chicago, IL
24. SPSS Inc. SPSS for Windows, Version 17 (2009), SPSS Inc, Chicago, IL
25. SAS Institute Inc. SAS/STAT User's Guide, Version 9.2 (2008), SAS Institute Inc, Cary, NC
26. Jones R. Longitudinal Data with Serial Correlation: A State-Space Approach (1993), Chapman & Hall, New York, NY
27. Michelson D., Faries D., Wernicke J., et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159 (2002) 1896-1901
28. Wilens T.E., Kratochvil C., Newcorn J.H., and Gao H. Do children and adolescents with ADHD respond differently to atomoxetine?. J Am Acad Child Adolesc Psychiatry 45 (2006) 149-157
29. Safren S.A., Otto M.W., Sprich S., Winett C.L., Wilens T.E., and Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 43 (2005) 831-842